BRAND REYNOLDS: Open Payments
NPI 1154325991 · TOOELE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$742 in 29 payments from 13 companies in 2025. Trend: 2023 $4,075 · 2024 $417 · 2025 $742
Food & beverage: $742
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $219 |
| Abbott Laboratories | 2 | $126 |
| ABBVIE INC. | 3 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $65 |
| Antares Pharma, Inc. | 1 | $51 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Lundbeck LLC | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: Wegovy, FREESTYLE LIBRE 3, CAPLYTA, REXULTI, VRAYLAR, XYOSTED, JOURNAVX, Ozempic.
Industry payments across UT — which companies pay providers there.
